JP Morgan increased its holding of Guangzhou Baiyunshan Pharmaceutical Holdings (00874) by approximately 26,720 shares at a price of around HK$18.9 per share.
On November 3, Xiaomo increased its stake in Baiyunshan (00874) by 267,243 shares, with a price of 18.9038 Hong Kong dollars per share, totaling approximately 5.0519 million Hong Kong dollars.
The latest data from the Hong Kong Stock Exchange shows that on November 3rd, JP Morgan increased its holdings of Guangzhou Baiyunshan Pharmaceutical Holdings (00874) by 267,243 shares, at a price of HK$18.9038 per share, with a total amount of approximately HK$5.0519 million. After the increase, the latest total number of shares held is approximately 17.6993 million shares, and the latest shareholding ratio is 8.04%.
Related Articles
IDREAMSKY (01119) granted 10,948,500 stock options.
KN Hospital(02120) spent about 944,100 Hong Kong dollars to repurchase 82,100 shares on November 7th.
WEIYE HOLDINGS (01570) recommends changing the auditor.
IDREAMSKY (01119) granted 10,948,500 stock options.
KN Hospital(02120) spent about 944,100 Hong Kong dollars to repurchase 82,100 shares on November 7th.
WEIYE HOLDINGS (01570) recommends changing the auditor.
RECOMMEND
Short Positions on Xiaomi (01810.HK) Surge 53% in a Week as Memory Price Spike Weighs on Sentiment
07/11/2025
Privatization Wave in Hong Kong Stocks: Exiting Liquidity Traps to Enable Strategic Transformation
07/11/2025
Over 30 Foreign Firms Attend Roundtable as Ministry of Commerce Signals Multiple Policy Shifts
07/11/2025
